β 2-Adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment

British Journal of Pharmacology

Volumn 158, Issue 7, 2009, Pages 1683-1694

  Choucair Jaafar, Nada ^a   Yalcin, Ipek ^a   Rodeau, Jean Luc ^a   Waltisperger, Elisabeth ^a   Freund Mercier, Marie José ^b   Barrot, Michel ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

2 adrenoceptor; Allodynia; Antidepressant; Neuropathy; Nortriptyline; Pain; Terbutaline

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BAMBUTEROL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FENOTEROL; ISOPRENALINE; NORTRIPTYLINE; PROPRANOLOL; RITODRINE; SALBUTAMOL SULFATE; SALMETEROL XINAFOATE; TERBUTALINE SULFATE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; PROPANOLAMINE DERIVATIVE;

ADRENERGIC RECEPTOR BLOCKING; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; LONG TERM CARE; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE; TREATMENT OUTCOME; ANIMAL; C57BL MOUSE; DRUG ADMINISTRATION; DRUG POTENTIATION; NEURALGIA; PAIN ASSESSMENT;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; MALE; MICE; MICE, INBRED C57BL; NEURALGIA; PAIN MEASUREMENT; PROPANOLAMINES; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA-2;

EID: 71249102058     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00510.x     Document Type: Article

References (45)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edition (2008 revision). Br J Pharmacol 153 : S1 S209.
2. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T et al. (2006). EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13 : 1153 1169.
3. Benbouzid M, Pallage V, Rajalu M, Waltisperger E, Doridot S, Poisbeau P et al. (2008a). Sciatic nerve cuffing in mice: A model of sustained neuropathic pain. Eur J Pain 12 : 591 599.
4. Benbouzid M, Choucair-Jaafar N, Yalcin I, Waltisperger E, Muller A, Freund-Mercier MJ et al. (2008b). Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice. Eur J Pain 12 : 1008 1017.
5. Benbouzid M, Gaveriaux-Ruff C, Yalcin I, Waltisperger E, Tessier LH, Muller A et al. (2008c). Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia. Biol Psychiatry 63 : 633 636.
6. Bentley GA, Starr J (1986). The antinociceptive action of some β-adrenoceptor agonists in mice. Br J Pharmacol 88 : 515 521.
7. Cheng HY, Pitcher GM, Laviolette SR, Whishaw IQ, Tong KI, Kockeritz LK et al. (2002). DREAM is a critical transcriptional repressor for pain modulation. Cell 108 : 31 43.
8. Cotter MA, Cameron NE (1998). Correction of neurovascular deficits in diabetic rats by beta2-adrenoceptor agonist and alpha1-adrenoceptor antagonist treatment: Interaction with the nitric oxide system. Eur J Pharmacol 343 : 217 223.
9. Coull A, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K et al. (2005). BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438 : 1017 1021.
10. Coyle JT, Duman RS (2003). Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38 : 157 160.
11. Diatchenko L, Anderson AD, Slade GD, Fillingim RB, Shabalina SA, Higgins TJ et al. (2006). Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet 141 : 449 462.
12. Dworkin RH, Corbin AE, Young JP Jr., Sharma U, LaMoreaux L, Bockbrader H et al. (2003). Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 60 : 1274 1283.
13. Funada M, Suzuki T, Sugano Y, Tsubai M, Misawa M, Ueda H et al. (1994). Role of β-adrenoceptors in the expression of morphine withdrawal signs. Life Sci 8 : 113 118.
14. Furukawa CT, Lokewick MJ (2007). β-adrenergic agonists. In : Lieberman P, Anderson JA (eds). Current Clinical Practice: Allergic Disease: Diagnosis and Treatment. Humana Press : Totowa, NJ, pp. 335 342.
15. Ghelardini C, Galeotti N, Bartolini A (2000). Antinociception induced by amitriptyline and imipramine is mediated by alpha2A-adrenoceptors. Jpn J Pharmacol 82 : 130 137.
16. Goldschmidt PL, Frances H, Simon P (1984). Stimulation of beta-adrenergic receptors and spontaneous motor activity in mice. Pharmacol Biochem Behav 21 : 177 180.
17. Gray AM, Pache DM, Sewell RD (1999). Do alpha2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds? Eur J Pharmacol 378 : 161 168.
18. Holdridge SV, Cahill CM (2007). Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Eur J Pain 11 : 685 693.
19. Khasar SG, McCarter G, Levine JD (1999). Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol 81 : 1104 1112.
20. McQuay HJM, Tramer BA, Nye D, Carroll P, Wiffen P, Moore A (1996). A systemic review of antidepressants in neuropathic pain. Pain 68 : 217 227.
21. Maizels M, McCarberg B (2005). Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician 71 : 483 490.
22. Merksey H, Bogduk N (1994). Classification of Chronic Pain. IASP Press : Seattle, WA.
23. Micó JA, Gibert-Rahola J, Casas J, Rojas O, Serrano MI, Serrano JS (1997). Implication of beta 1- and beta 2-adrenergic receptors in the antinociceptive effect of tricyclic antidepressants. Eur Neuropsychopharmacol 7 : 139 145.
24. Micó JA, Ardid D, Berrocoso E, Eschalier A (2006). Antidepressants and pain. Trends Pharmacol Sci 27 : 348 354.
25. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA (1999). Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159 : 1931 1937.
26. Mosconi T, Kruger L (1996). Fixed-diameter polyethylene cuffs applied to the rat sciatic nerve induce a painful neuropathy: ultrastructural morphometric analysis of axonal alterations. Pain 64 : 37 57.
27. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ et al. (2007). Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 12 : 13 21.
28. Nackley-Neely AG, Tan KS, Fecho K, Flood P, Diatchenko L, Maixner W (2007). Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain 128 : 199 208.
29. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002). Neurobiology of depression. Neuron 34 : 13 25.
30. Nicholson R, Dixon AK, Spanswick D, Lee K (2005). Noradrenergic receptor mRNA expression in adult rat superficial dorsal horn and dorsal root ganglion neurons. Neurosci Lett 380 : 316 321.
31. Ozdǒan UK, Lähdesmäki J, Mansikka H, Scheinin M (2004). Loss of amitriptyline analgesia in alpha 2A-adrenoceptor deficient mice. Eur J Pharmacol 485 : 193 196.
32. Parada CA, Yeh JJ, Joseph EK, Levine JD (2003). Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat. Eur J Neurosci 17 : 1847 1852.
33. Pitcher GM, Ritchie J, Henry JL (1999). Nerve constriction in the rat: Model of neuropathic, surgical and central pain. Pain 83 : 37 46.
34. Rosenborg J, Larsson P, Nyberg L (2000). Pharmacokinetics of bambuterol during oral administration of plain tablets and solution to healthy adults. Br J Clin Pharmacol 49 : 199 206.
35. Ryall JG, Plant DR, Gregorevic P, Sillence MN, Lynch GS (2004). Beta2-agonist administration reverses muscle wasting and improves muscle function in aged rats. J Physiol 555 : 175 188.
36. Ryberg M, Johansson I (1995). The effects of long-term treatment with salmeterol and salbutamol on the flow rate and composition of whole saliva in the rat. Arch Oral Biol 40 : 187 191.
37. Serradeil-Le Gal C, Valette G, Foulon L, Germain G, Advenier C, Naline E et al. (2004). SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl) -3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl) -benzamide, hydrochloride): A new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor. J Pharmacol Exp Ther 309 : 414 424.
38. Sindrup SH, Otto M, Finnerup NB, Jensen TS (2005). Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 96 : 399 409.
39. Thornhill JA, Desautels M (1984). Is acute morphine hyperthermia of unrestrained rats due to selective activation of brown adipose tissue thermogenesis? J Pharmacol Exp Ther 231 : 422 429.
40. Tsankova N, Renthal W, Kumar A, Nestler EJ (2007). Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8 : 355 367.
41. Wallace DL, Huan MH, Graham DL, Green TA, Vialou V, Iniguez SD et al. (2009). CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits. Nature Neurosci 12 : 200 209.
42. Yalcin I, Aksu F, Bodard S, Chalon S, Belzung C (2007). Antidepressant-like effect of tramadol in the unpredictable chronic mild stress procedure: Possible involvement of the noradrenergic system. Behav Pharmacol 18 : 623 631.
43. Yalcin I, Choucair-Jaafar N, Benbouzid M, Tessier LH, Muller A, Hein L et al. (2009a). β2-adrenoceptors are critical for antidepressant treatment of neuropathic pain. Ann Neurol 65 : 218 225.
44. Yalcin I, Tessier LH, Petit-Demoulière N, Doridot S, Hein L, Freund-Mercier MJ et al. (2009b). β2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain. Neurobiol Dis 33 : 386 394.
45. Zarkovic JP, Marenk M, Valovirta E, Kuusela AL, Sandahl G, Persson B et al. (2000). One-year safety study with bambuterol once daily and terbutaline three times daily in 2-12-year-old children with asthma. The Bambuterol Multicentre Study Group. Pediatr Pulmonol 29 : 424 429. (Pubitemid 30346467)